Compare CMPS & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | IPI |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United Kingdom | United States |
| Employees | 166 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.5M | 380.0M |
| IPO Year | 2020 | 2008 |
| Metric | CMPS | IPI |
|---|---|---|
| Price | $6.59 | $28.35 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 8 | 1 |
| Target Price | $16.43 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.2M | 135.7K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $222,728,000.00 |
| Revenue This Year | N/A | $23.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $2.25 | $20.86 |
| 52 Week High | $7.15 | $39.01 |
| Indicator | CMPS | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 57.72 |
| Support Level | $6.56 | $26.26 |
| Resistance Level | $7.15 | $28.66 |
| Average True Range (ATR) | 0.37 | 1.01 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 43.46 | 63.84 |
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.